MedTrace Logo

Gender-Relevant Tobacco Cessation Among Women in Brazil

NCT03845413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 338

Last updated 2019-11-05

No results posted yet for this study

Summary

The overall goal of this renewal is three-fold: (1) to continue to sustain and strengthen the network; (2) to conduct a group randomized controlled trial to assess the efficacy of a theory-based, culturally- and gender-relevant Community Health Worker intervention for Brazilian women "light smokers" that will augment the smoking cessation programs offered through the public health system; and (3) to expand our current Career Development and Research Training Program to the other two major tobacco growing states in order to develop a cadre of well-trained researchers who will continue to develop and implement gender-relevant comprehensive tobacco control strategies at all levels.

Conditions

  • Tobacco Use Cessation

Interventions

BEHAVIORAL

Control

Schedule an appointment to attend tobacco cessation at Basic Health Unit

BEHAVIORAL

12-home visits by the Community Health Worker + referring to an appointment for the participant to attend the tobacco cessation program

12-home visits by the Community Health Worker + referring to an appointment for the participant to attend the tobacco cessation program

Sponsors & Collaborators

  • Pontifícia Universidade Católica do Paraná

    collaborator OTHER

  • Universidade Estadual de Londrina

    collaborator OTHER

  • University of Massachusetts, Worcester

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-20
Primary Completion
2018-07-30
Completion
2019-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03845413 on ClinicalTrials.gov